Comorbid Patterns with Alcohol Use Disorders
酒精使用障碍的共病模式
基本信息
- 批准号:8207257
- 负责人:
- 金额:$ 36.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:African AmericanAgeAge of OnsetAlcohol abuseAlcohol consumptionAlcohol dependenceAlcohol or Other Drugs useAlcoholsAnxietyAnxiety DisordersBehaviorCharacteristicsClassificationClinicalClinical ResearchComplexConduct DisorderCountryDSM-IVDataData AnalysesData SetDependenceDevelopmentDiagnosisDiagnosticDiseaseDrug usageDysthymic DisorderEpidemiologyEthnic OriginEventFamilyFemaleGenderGeneralized Anxiety DisorderGoalsGrantHealthHealth InsuranceHispanicsImmigrationIncidenceIndividualMajor Depressive DisorderManicMediator of activation proteinMental DepressionMental disordersMethodsMexican AmericansMood DisordersMoodsNIH Program AnnouncementsNational originNot Hispanic or LatinoOutcomePanic DisorderPathway interactionsPatternPersonalityPopulationPrevalencePreventive InterventionProbabilityPsyche structurePsychiatric DiagnosisRaceRaspberriesRecording of previous eventsRelative (related person)ReportingRiskSample SizeSamplingSampling StudiesSelection BiasSocial FunctioningSocial PhobiaSpecific PhobiaStagingStructureSubgroupSubstance Use DisorderSurveysSurvival AnalysisSymptomsSyndromeTechniquesTestingTimeTobacco useUnited StatesVariantWomanWorkaddictionalcohol epidemiologyalcohol involvementalcohol related problemalcohol use disorderalcohol use initiationdisabilitydrinkingdrinking behaviorethnic minority populationhigh riskhypomaniaimprovedinformation gatheringmalemenpopulation basedpreventracial and ethnicresponsesextime usetrend
项目摘要
This revised R01 application is in response to the Program Announcement (PA-07-071) for "Secondary
Analysis of Existing Alcohol Epidemiology Data". The overall goals for this application are to assess patterns of
alcohol use disorders (AUD) with comorbid anxiety and mood conditions, to examine whether transition to
alcohol dependence is altered by the presence of specific psychiatric disorders and symptoms, and if these
patterns differ among gender and race-ethnicity subgroups. Although prior population-based and clinical
studies have provided evidence for the comorbid occurrence of alcohol and with both mood and anxiety
disorders, there have been little assessment of patterns of these co-occurrences, their relationship with
transition to alcohol dependence, and whether these patterns differ for specific subgroups of the population.
Using the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) dataset, we propose
to 1) assess the comorbid prevalence, incidence and strength of association of AUD with anxiety symptoms
and disorders (panic, social phobia, specific phobia and generalized anxiety disorder), and 2) mood symptoms
and disorders (major depression, dysthymia, mania, and hypomania). In addition, using data from the National
Longitudinal Alcohol Epidemiologic Survey (NLAES), 3) we aim to assess whether prevalence and comorbid
trends of alcohol abuse and dependence with major depression have changed during the intervals between the
NLAES (1991-92), and with wave 1 (2001-02) and wave 2 NESARC (2004-05). Using survival analyses, 4) we
intend to assess whether age of (a) onset of AUD, (b) first symptom of excessive alcohol use, and (c) alcohol
use initiation varies by presence and type of anxiety and mood condition. Using latent class analysis, 5) we
also aim to examine the relationship of anxiety and mood disorders with patterns of excessive alcohol use
symptoms, and using latent transition analyses to 6) assess patterns of transition to alcohol dependence. In
addition, 7) for each specific aim, we will examine the bidirectional assessment of these associations. The
proposed analyses should further our understanding of the comorbid patterns and relationships of alcohol,
anxiety and mood symptoms and disorders. Assessment of patterns of these comorbid conditions potentially
will improve our ability to identify high risk groups which may provide targets for early prevention and
intervention efforts. Alcohol, mood and anxiety disorders together constitute some of the largest groups of
mental and substance use conditions worldwide. Yet, the ability to examine the relationship of these conditions
in a population-based sample (reducing potential selection biases), providing DSM-IV diagnostic criteria, within
a sample large enough to assess potentially diverse associations among gender and race-ethnicity subgroups
until now has been quite limited. The proposed analyses should fill in many gaps in our understanding of these
co-occurring conditions.
此修订后的R01申请是响应“次要的计划公告(PA-07-071)
对现有酒精流行病学数据的分析”。此应用的总体目标是评估
与合并焦虑和情绪状况的酒精使用障碍(AUD),以检查是否过渡到
酒精依赖性因特定的精神疾病和症状而改变,如果这些疾病和症状
性别和种族种族亚组的模式不同。虽然先前基于人群和临床
研究提供了证据证明酒精的合并症以及情绪和焦虑
疾病,几乎没有评估这些共发生的模式,它们与
过渡到酒精依赖性,以及这些模式是否在人群的特定亚组中有所不同。
使用国家酒精和相关条件的国家流行病学调查(NESARC)数据集,我们建议
到1)评估合并症的患病率,发病率和与焦虑症状的相关性
和疾病(恐慌,社会恐惧症,特定恐惧症和普遍焦虑症),2)情绪症状
和疾病(重度抑郁症,心律失常,躁狂和躁狂症)。此外,使用国家的数据
纵向酒精流行病学调查(NLAE),3)我们旨在评估患病率和合并症是否
酗酒趋势和与重度抑郁症的依赖趋势在间隔之间发生了变化
Nlaes(1991-92),以及Wave 1(2001-02)和Wave 2 Nesarc(2004-05)。使用生存分析,4)我们
打算评估(a)aud的年龄,(b)过度饮酒的第一个症状;(c)酒精
使用启动随着焦虑和情绪状况的存在而有所不同。使用潜在类分析,5)我们
还旨在检查焦虑和情绪障碍与过度饮酒模式的关系
症状,并使用潜在的过渡分析到6)评估过渡到酒精依赖的模式。在
补充7)对于每个特定目标,我们将检查这些关联的双向评估。这
建议的分析应进一步了解我们对酒精的合并模式和关系的理解,
焦虑和情绪症状和疾病。可能会评估这些合并条件的模式
将提高我们识别高风险群体的能力,这可能为早期预防提供目标和
干预工作。酒精,情绪和焦虑症共同构成了一些最大的群体
全球精神和物质使用条件。但是,检查这些条件关系的能力
在基于人群的样本(减少潜在的选择偏见)中,提供了DSM-IV诊断标准
一个足够大的样本可以评估性别和种族子组之间的潜在多样化关联
到目前为止一直有限。提议的分析应填补我们对这些分析的理解空白
同时出现的条件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rosa M. Crum其他文献
Rosa M. Crum的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rosa M. Crum', 18)}}的其他基金
Substance Use Treatment Outcomes: Effect of Psychiatric Comorbidity
药物使用治疗结果:精神共病的影响
- 批准号:
10634124 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别:
The Impact of State Healthcare Reforms on Treatment of Substance Use Disorders
国家医疗改革对药物滥用障碍治疗的影响
- 批准号:
9225192 - 财政年份:2016
- 资助金额:
$ 36.59万 - 项目类别:
The Impact of State Healthcare Reforms on Treatment of Substance Use Disorders
国家医疗改革对药物滥用障碍治疗的影响
- 批准号:
9412821 - 财政年份:2016
- 资助金额:
$ 36.59万 - 项目类别:
相似国自然基金
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
晶状体mtDNA氧化损伤修复与线粒体自噬的空间差异及其调控干预在年龄相关性白内障发病中的作用
- 批准号:82171038
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
FoxO3a通路抑制在年龄相关性白内障发病机制中的调控作用
- 批准号:82070942
- 批准年份:2020
- 资助金额:57 万元
- 项目类别:面上项目
肠道微生态参与年龄相关性黄斑变性的发病机制及固本清目方的干预作用
- 批准号:81973912
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
ODRP泛素化经LECs外泌体释放和自噬降解调控年龄相关性白内障的发病
- 批准号:81974129
- 批准年份:2019
- 资助金额:57 万元
- 项目类别:面上项目
相似海外基金
Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
- 批准号:
10658457 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别:
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations
SARS-CoV-2 感染和遗传变异的相互作用对祖先和混血人群认知能力下降和阿尔茨海默病风险的影响
- 批准号:
10628505 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别:
Leveraging Spatial Epidemiology to Reduce Hypertension Disparities
利用空间流行病学减少高血压差异
- 批准号:
10855071 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别:
Early Cognitive Impairment as a function of Alzheimer's Disease and Trauma
阿尔茨海默病和创伤导致的早期认知障碍
- 批准号:
10479319 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别:
Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry
与非洲血统相关的多发性骨髓瘤肿瘤生物学差异
- 批准号:
10656009 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别: